BRIEF-Abeona Therapeutics receives orphan drug designation in the EU for ABO-201 gene therapy program
Jan 3 Abeona Therapeutics Inc :
* Abeona Therapeutics receives orphan drug designation in the European Union for ABO-201 gene therapy program in juvenile batten disease
* Abeona Therapeutics Inc - "This designation helps advance ABO-201 program and we look forward to initiating human clinical trials later this year" Source text for Eikon: Further company coverage:
Google gets Australian tax office demand to pay more, says to fight it
SYDNEY, April 29 Alphabet Inc's Google said it will challenge amended tax assessments issued by the Australian Taxation Office (ATO), which is trying to claw back billions of dollars from multinational corporations citing unpaid taxes.